IPOs and Secondaries
IPOs and Secondaries Articles
Jaguar Animal Health has filed an S-1 form with the U.S. Securities and Exchange Commission (SEC) for a secondary offering.
Published:
Last Updated:
OTG EXP has filed with the U.S. Securities and Exchange Commission (SEC) in regards to its initial public offering (IPO).
Published:
Last Updated:
Mapi Pharma has amended its filing with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Published:
Last Updated:
Before readers think that this may be a hoax, it is not. How would most investors feel about buying into an Argentine financial group that owns a bank? After all, the financial history of Argentina...
Published:
Last Updated:
Spring Bank Pharmaceuticals has filed with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).
Published:
Last Updated:
Visterra has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Published:
Last Updated:
GMS has amended its filing with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).
Published:
Last Updated:
PLx Pharma has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Published:
Last Updated:
Transfirst Holdings has amended its filing with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Published:
Last Updated:
Syndax Pharmaceuticals has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Published:
Last Updated:
The U.S. Securities and Exchange Commission (SEC) has received a filing from Tabula Rasa HealthCare regarding its initial public offering (IPO).
Published:
Last Updated:
Editas Medicine has filed with the U.S. Securities and Exchange Commission (SEC) in regards to its initial public offering (IPO).
Published:
Last Updated:
Corvus Pharmaceuticals has filed with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).
Published:
Last Updated:
Akebia Therapeutics plans on raising capital, according to its most recent proposed public offering.
Published:
Last Updated:
Reata Pharmaceuticals has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Published:
Last Updated: